Vanderbilt Patient With Melanoma Receives TIL Therapy
Vanderbilt Health News has issued a one-line notice confirming a melanoma patient received tumor-infiltrating lymphocyte therapy, with no patient demographics, AJCC stage, prior therapy, product iden…